国际标准期刊号: 2332-0702

口腔卫生与健康杂志

开放获取

我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。

开放获取期刊获得更多读者和引用
700 种期刊 15,000,000 名读者 每份期刊 获得 25,000 多名读者

索引于
  • 哥白尼索引
  • 谷歌学术
  • 打开 J 门
  • 期刊目录
  • 参考搜索
  • 哈姆达大学
  • 亚利桑那州EBSCO
  • OCLC-世界猫
  • 普布隆斯
  • 日内瓦医学教育与研究基金会
  • 欧洲酒吧
  • ICMJE
分享此页面

抽象的

In The Era of Modern Dental Care Anti-Thrombotic Medications

Erica James

Due to the development of novel anti-thrombotic medicines and modifications to the approved indications for their use, anti-thrombotic treatment has undergone significant changes in recent years. Dentists are consequently seeing more patients who are receiving anti-thrombotic therapy and who have a higher risk of bleeding. The current research seeks to evaluate the literature on current anti-thrombotic therapies and provide details on their dental implications. The material published between 2000 and 2016 was searched online. Both articles discussing evidence-based clinical recommendations for anti-thrombotic therapies and publications documenting the use of anti-thrombotic drugs were incorporated. The publications were reviewed based on the treatment protocol criteria and their applicability to dentistry. A total of 5,539 papers were found: 132 of these articles mention direct anti-thrombotic drugs, while 56 of the 554 evidence-based clinical guidelines found dealt with anti-thrombotic therapy procedures. During dental procedures, bleeding is a possibility. Dentists need to be knowledgeable about the effects of new generation anti-thrombotic medications on dental treatment as well as practical ways to achieve haemostasis because more patients are taking them [1-5].